Masimo announced today a new study published in the May 2012 edition of the British Journal of Anaesthesia demonstrates that Masimo's acoustic respiration rate (RRa(TM)) from rainbow® Acoustic Monitoring provides similar respiration rate accuracy as capnometry for extubated patients.(1)
Advanced Brain Monitoring, Inc. announced the world-wide launch of an important new product in the treatment of sleep apnea, the Apnea Guard®. Apnea Guard is the first validated temporary oral appliance with clinical equivalence to custom oral appliances for the treatment of snoring and sleep apnea. Apnea Guard is cleared by the FDA to be fitted for a patient by a trained healthcare professional and worn for up to 30-nights.
Covidien and GE Healthcare, leading global providers of healthcare products and recognized innovators in patient monitoring and respiratory care devices, today announced a five-year, global collaboration to incorporate Covidien measurement technologies into GE Healthcare patient monitors.
ResMed Inc. recently announced the release of its new patient compliance management solution, EasyCare Online. The innovative new tool aggregates usage and efficacy data from obstructive sleep apnea patients who use continuous positive airway pressure (CPAP) treatment. The data can be used by sleep labs, home medical equipment and other health care providers involved in managing obstructive sleep apnea. The new tool employs a secure, cloud-based system consistent with the leading health information privacy and security standards, including those mandated by the latest federal regulations.
O2 Concepts has reached full production on its new state-of-the-art portable oxygen concentrator. The Oxlife Independence was designed for the PROVIDER by delivering the lowest lifecycle costs for today’s declining reimbursement environment.
In just one week, more than 50,000 snorers across America requested a free sample of SnoreRx(r), Sleep Scentsations' new non-invasive, all-natural pillow liners that help suppress snoring and provide a more restful night of sleep.
Infusion Brands, a global consumer products company, offered consumers a free trial offer of its product through getsnorerx.com and received more than 50,000 requests within days. Each trial consumer will receive one SnoreRx pillow liner, which is good for three nights of snore-free sleep.
Forest Laboratories, Inc. and Almirall, S.A. announced today that the U.S. Food and Drug Administration (FDA) will require a three-month extension to complete its review of the data supporting the New Drug Application (NDA) for aclidinium bromide, a new long-acting antimuscarinic for the maintenance treatment of Chronic Obstructive Pulmonary Disease (COPD). No additional data has been requested by the agency to complete the review. FDA action is now expected by July 2012.
Philips Respironics recently launched an enhanced version of the Actical physical activity monitoring system. The device is intended for researchers who need real-time ambulatory monitoring in real-world applications. The Actical system allows users to collect and examine high-resolution data easily on a subject’s physical activity, steps, and energy expenditure levels for longer periods of time than was possible with the previous Actical system.